Schonfeld Strategic Advisors LLC

Position in ADPT — Adaptive Biotechnologies Corp

CIK 1665241 NEW YORK, NY

Position in ADPT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,639,322

+$1,845,582 QoQ

Shares Held

262,199

+137.4% QoQ

Ownership

0.164%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Schonfeld Strategic Advisors LLC holds $128,301,386 across 20 Diagnostics & Research names. ADPT ranks #11 (2.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ILMN	Illumina, Inc.	178,851	$22,045,174
2	QGEN	Qiagen N.V.	493,645	$19,765,545
3	A	Agilent Technologies, Inc.	132,823	$15,139,165
4	TWST	Twist Bioscience Corp	258,604	$12,288,862
5	WAT	Waters Corp /De/	32,254	$9,605,241
6	CRL	Charles River Laboratories International, Inc.	52,959	$9,135,427
7	IDXX	Idexx Laboratories Inc /De	15,003	$8,430,035
8	DHR	Danaher Corp /De/	40,074	$7,598,030

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,639,322	262,199	+137.4%	Shares	Sole	2026-05-15
2025-12-31	$1,793,740	110,452	+427.4%	Shares	Sole	2026-02-17
2025-09-30	$313,322	20,944	-21.0%	Shares	Sole	2025-11-14
2022-03-31	$367,820	26,500	-26.8%	Shares	Sole	2022-05-16
2021-12-31	$1,015,772	36,200	+24.3%	Shares	Sole	2022-02-14
2021-03-31	$1,172,049	29,112	-41.8%	Shares	Sole	2021-05-17
2020-09-30	$2,431,500	50,000	+137.0%	Shares	Sole	2020-11-19
2020-06-30	$1,020,818	21,100	—	Shares	Sole	2020-09-15
No filing history on record for this holder in this stock.